AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 177 filers reported holding AXSOME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,869,278 | +90.4% | 26,746 | +95.7% | 0.00% | +100.0% |
| Q2 2023 | $981,967 | +1.6% | 13,665 | -12.8% | 0.00% | 0.0% |
| Q1 2023 | $966,032 | +31.2% | 15,662 | +64.1% | 0.00% | 0.0% |
| Q4 2022 | $736,052 | -99.9% | 9,543 | -39.4% | 0.00% | 0.0% |
| Q3 2022 | $702,140,000 | +80.4% | 15,736 | +54.9% | 0.00% | 0.0% |
| Q2 2022 | $389,166,000 | -68.4% | 10,161 | -65.9% | 0.00% | -50.0% |
| Q1 2022 | $1,231,601,000 | -54.9% | 29,756 | -58.8% | 0.00% | -50.0% |
| Q4 2021 | $2,729,681,000 | +1153.1% | 72,252 | +993.2% | 0.00% | – |
| Q3 2021 | $217,833,000 | -8.4% | 6,609 | +87.5% | 0.00% | – |
| Q2 2021 | $237,729,000 | -33.2% | 3,524 | -43.9% | 0.00% | -100.0% |
| Q1 2021 | $355,913,000 | -16.8% | 6,286 | +19.8% | 0.00% | 0.0% |
| Q4 2020 | $427,555,000 | -8.5% | 5,248 | -19.9% | 0.00% | 0.0% |
| Q3 2020 | $467,044,000 | +320.5% | 6,555 | +385.6% | 0.00% | – |
| Q2 2020 | $111,078,000 | -96.3% | 1,350 | -97.3% | 0.00% | -100.0% |
| Q1 2020 | $2,981,740,000 | +757.8% | 50,684 | +1407.1% | 0.01% | +500.0% |
| Q4 2019 | $347,600,000 | +293.4% | 3,363 | -23.0% | 0.00% | – |
| Q3 2019 | $88,348,000 | +2030.9% | 4,365 | +2611.2% | 0.00% | – |
| Q2 2019 | $4,146,000 | +9541.9% | 161 | +5266.7% | 0.00% | – |
| Q1 2019 | $43,000 | +437.5% | 3 | 0.0% | 0.00% | – |
| Q4 2018 | $8,000 | -20.0% | 3 | 0.0% | 0.00% | – |
| Q3 2018 | $10,000 | 0.0% | 3 | 0.0% | 0.00% | – |
| Q2 2018 | $10,000 | +42.9% | 3 | 0.0% | 0.00% | – |
| Q1 2018 | $7,000 | -58.8% | 3 | 0.0% | 0.00% | – |
| Q4 2017 | $17,000 | 0.0% | 3 | 0.0% | 0.00% | – |
| Q3 2017 | $17,000 | 0.0% | 3 | 0.0% | 0.00% | – |
| Q2 2017 | $17,000 | -93.7% | 3 | -95.7% | 0.00% | – |
| Q1 2017 | $269,000 | -82.1% | 69 | -69.1% | 0.00% | – |
| Q4 2016 | $1,505,000 | -74.7% | 223 | -70.5% | 0.00% | – |
| Q3 2016 | $5,957,000 | +79.5% | 756 | +71.8% | 0.00% | – |
| Q2 2016 | $3,318,000 | – | 440 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
| Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
| WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
| MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
| RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
| RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
| Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
| Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
| Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |